hVIVO Investor

hVIVO is a contract virology research company that aims to develop antivirals and vaccines in the field of biomedical research.
Technology: Data-driven Technologies
Industry: Longevity Industry 2022
Headquarters: London, England, United Kingdom
Founded Date: 1988
Employees Number: 501-1000
Funding Status: IPO
Investor Type: Investor
Number Of Exits: Series B
Total Funding: $2.6M
Estimated Revenue: $10M to $50M

Visit Website
BD@hvivo.com
https://www.twitter.com/hvivo_uk
Register and Claim Ownership